Diabetes Metab J.  2014 Jun;38(3):194-196. 10.4093/dmj.2014.38.3.194.

It's Still Not Too Late to Make a Change: Current Status of Glycemic Control in Korea

• Kim SY

• KMID: 2280689
• DOI: http://doi.org/10.4093/dmj.2014.38.3.194

Abstract

No abstract available.

MeSH Terms

Korea

Reference

1. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J. 2011; 35:303–308.

2. Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang MJ, Kim Y, Oh K, Kim DJ, Cha BY. Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J. 2013; 37:349–357.

3. Pickup JC, Williams G. Textbook of diabetes. 3rd ed. Malden: Blackwell Science;2003.

4. Statistics Korea: Causes of death statistics 2012. updated 2013 Sep 25. Available from: http://kostat.go.kr.

5. Rhee SY, Chon S, Kwon MK, Park Ie B, Ahn KJ, Kim IJ, Kim SH, Lee HW, Koh KS, Kim DM, Baik SH, Lee KW, Nam MS, Park YS, Woo JT, Kim YS. Prevalence of chronic complications in korean patients with type 2 diabetes mellitus based on the korean national diabetes program. Diabetes Metab J. 2011; 35:504–512.

6. The Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Diabetes fact sheet in Korea 2013. Seoul: Korean Diabetes Association;2013.

7. Lee KW. Costs of diabetes mellitus in Korea. Diabetes Metab J. 2011; 35:567–570.

8. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103–117.

9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837–853.

10. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358:580–591.

11. Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care. 2009; 32:2016–2020.

12. Jeon JY, Kim DJ, Ko SH, Kwon HS, Lim S, Choi SH, Kim CS, An JH, Kim NH, Won JC, Kim JH, Cha BY, Song KH. The Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Current status of glycemic control of patients with diabetes in Korea: the Fifth Korea National Health and Nutrition Examination Survey. Diabetes Metab J. 2014; 38:197–203.

13. Wajchenberg BL. beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007; 28:187–218.

14. Ko SH, Park SA, Cho JH, Ko SH, Shin KM, Lee SH, Song KH, Park YM, Ahn YB. Influence of the duration of diabetes on the outcome of a diabetes self-management education program. Diabetes Metab J. 2012; 36:222–229.

15. Choi MJ, Yoo SH, Kim KR, Bae YM, Ahn SH, Kim SS, Min SA, Choi JS, Lee SE, Moon YJ, Rhee EJ, Park CY, Lee WY, Oh KW, Park SW, Kim SW. Effect on glycemic, blood pressure, and lipid control according to education types. Diabetes Metab J. 2011; 35:580–586.